"Receptors, Interleukin-6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.
| Descriptor ID |
D019947
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.400
|
| Concept/Terms |
Receptors, Interleukin-6- Receptors, Interleukin-6
- Receptors, Interleukin 6
- IL-6 Receptors
- IL 6 Receptors
- Receptors, IL-6
- Receptors, IL 6
- IL6 Receptors
- Receptors, IL6
- Interleukin 6 Receptor
- Receptor, Interleukin 6
- Interleukin-6 Receptors
- Interleukin 6 Receptors
- IL-6 Receptor
- IL 6 Receptor
- Receptor, IL-6
- IL6 Receptor
- Receptor, IL6
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-6".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-6".
This graph shows the total number of publications written about "Receptors, Interleukin-6" by people in this website by year, and whether "Receptors, Interleukin-6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-6" by people in Profiles.
-
Haraoui B, Casado G, Czirj?k L, Taylor A, Bernasconi C, Reiss W, Caporali R. Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies. Clin Exp Rheumatol. 2017 Nov-Dec; 35(6):899-906.
-
Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond VK, Wang R, Drew AF, Gushiken F, Lamkin D, Collins K, DeGeest K, Lutgendorf SK, Chiu W, Lopez-Berestein G, Afshar-Kharghan V, Sood AK. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012 Feb 16; 366(7):610-8.
-
Helwig BG, Craig RA, Fels RJ, Blecha F, Kenney MJ. Central nervous system administration of interleukin-6 produces splenic sympathoexcitation. Auton Neurosci. 2008 Aug 18; 141(1-2):104-111.
-
Helwig BG, Musch TI, Craig RA, Kenney MJ. Increased interleukin-6 receptor expression in the paraventricular nucleus of rats with heart failure. Am J Physiol Regul Integr Comp Physiol. 2007 Mar; 292(3):R1165-73.
-
Nowell MA, Richards PJ, Fielding CA, Ognjanovic S, Topley N, Williams AS, Bryant-Greenwood G, Jones SA. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2006 Jul; 54(7):2084-95.
-
Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 2005 Aug 25; 24(36):5552-60.